Form 4: QuidelOrtho Director Ann D. Rhoads Reports Stock Unit Release
SEC Form 4 Filing
Director Ann D. Rhoads reports the release of restricted stock units into QuidelOrtho common stock on May 18, 2025, through a deferred compensation program.
Summary
- On May 18, 2025, Ann D. Rhoads, a director of QuidelOrtho Corp, reported the release of restricted stock units.
- These units converted into 427 and 128 shares of common stock, respectively.
- The transactions were executed at a price of $0 per share.
- Following these transactions, Rhoads directly owns 8,687 shares of QuidelOrtho common stock.
- The release of restricted stock units was deferred under QuidelOrtho's deferred compensation program for non-employee directors.
Sentiment
Score: 5
Explanation: This is a neutral report on stock transactions by a company director, with no inherent positive or negative implications for the company's performance.
Industry Context
This Form 4 filing is a routine disclosure related to insider transactions and provides transparency to the market regarding the holdings of company directors.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding director's holdings.
Key Dates
| Date | Description |
|---|---|
| 05/18/2025 | Release of restricted stock units and conversion into common stock. |
| 05/20/2025 | Date of signature for the Form 4 filing. |
Keywords
QuidelOrtho, Director, Ann D. Rhoads, Restricted Stock Units, Common Stock, Form 4, Deferred Compensation, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.